Cresco Labs, a multi-state cannabis operator, said it has launched its Remedi cannabis brand as well as its Renew and Realign spray tinctures and Renew capsules in New York.
Cresco Labs has also received approval from the New York Department of Health for both THC only and 1:1 CBD to THC capsules, spray tinctures, syringes and vape products from its Remedi line.
The company noted that the launch of the Remedi brand is the next step in expanding its branded wholesale business in New York.
“Remedi products are specifically tailored to meet the needs of medical patients, and they come in precise doses and form factors similar to other health and wellness products. Our new-to-market Sativa spray tincture, as well as new-to-market Hybrid and Indica capsules, are the only category-specific spray tinctures and capsules currently offered in the state,” said Greg Butler, Chief Commercial Officer at Cresco Labs.
Remedi is a wellness-focused brand that was originally created for patients with…